White Matthew J sold $45.3M of LIN

White Matthew J (Chief Financial Officer) sold 86,833 shares of LINDE PLC (LIN) at an average of $521.21 ($518.50–$525.00, $45.26M total) across 4 trades on 2026-11-04.

Original reporting
SEC EDGAR · White Matthew J
Published Nov 6, 2026, 6:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 6:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIN
Bearish
medium confidence
Mentioned
$LIN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LINBearishLow
01

Why it matters

Traders may briefly reassess near-term sentiment toward LIN based on CFO selling, but the disclosure does not provide new company performance, guidance, or strategic information.

02

Market read

A CFO open-market sale totaling about $45.3M is disclosed, which can influence short-term sentiment but is unlikely to drive a sustained repricing alone.

03

What to watch

Insider sales often cluster around tax, planned purchases, or personal cash needs; without context on prior grants/sales cadence, the signal may be overstated.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed 2026-11-06, covering sales executed 2026-11-04.

Background

The article summarizes an SEC Form 4 insider transaction by Linde PLC’s CFO, including trade dates, share counts, and weighted-average prices.

Company-level read

Ticker impact

$LINBearishMedium confidence
Context

Linde CFO Matthew J White sold about $45.3M of LIN shares via an open-market Form 4 transaction on 2026-11-04.

Expected impact

Likely mild downward pressure or increased caution as traders weigh insider-sale optics against ongoing fundamentals.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure with sizable dollar value, but it does not include a 10b5-1 plan and provides no accompanying operational or guidance change.

Market effects

Limited read-through for industrial gases peers; this is company-specific insider activity without sector-wide catalyst.

Minimal, as the event is a US-listed ADR/stock insider transaction with no stated macro linkage.

Low; no deal, regulation, or operational update affecting global industrial gas demand is disclosed.

Counterpoint

The sale could be routine liquidity or diversification, and the absence of a stated 10b5-1 plan does not necessarily imply bearish expectations.

Key entities

  • Linde PLC

    Subject of the Form 4 insider sale disclosure (LIN).

  • Matthew J. White

    Chief Financial Officer who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LINMedAI 8/10

Linde PLC (LIN) (Q3 2026) Earnings Call Highlights: Record Sales, Profit and EPS

Linde PLC (LIN) reported Q3 2026 record sales, profit, and EPS, but faced challenges in non-gas segments like Lincare, which reduced EPS growth by 2%. Q4 EPS guidance is $4.40-$4.50, a 3% sequential decline due to FX headwinds and seasonality. Europe and China markets remain weak. Management is evaluating strategic options for Lincare and expects no near-term recovery in Europe or China. Electronics growth is strong, supported by $2B in projects.

$LINMed

Linde plc Q3 2026 Earnings Call Summary

Linde plc reported Q3 2026 earnings, including a $425M restructuring charge. Lincare was moved to the Global Other segment. Chemicals and Energy grew 12%, Electronics 15%. Q4 EPS guidance is $4.40-$4.50. Management expects restructuring benefits by H2 2027 and Woodside ammonia project completion by H1 2027.

$LINMedAI 8/10

Linde Q3 Earnings Call Highlights

Linde (LIN) reported varied demand across regions and sectors in Q3, with electronics sales up 15% and chemicals/energy up 12%. U.S. packaged-gas growth remained in the low teens, while Europe saw flat market conditions. Linde's project backlog is near $8 billion, with the Woodside project expected to contribute financially in 2024. The company forecasted Q4 EPS of $4.40-$4.50, with full-year EPS at $17.82-$17.92.

$LINHighAI 8/10

Linde delivers a good quarter and puts in a fix for an overhang on the stock

Linde reported record Q3 revenue of $9.4B, up 9.2%, and adjusted EPS of $4.59, beating estimates. Shares fell 1% despite strong results due to light Q4 guidance. CEO addressed Lincare restructuring, taking a $425M charge. Sales grew in electronics, chemicals, and energy, with space propellant demand noted. Full-year EPS outlook raised to $17.87, in line with consensus. Linde maintains a $550 price target.